Advertisement

Thrombolysis: Peripheral Arterial Applications

  • Carlos E. Donayre
  • Kenneth Ouriel

Abstract

Vascular surgeons have been able to perform complex revascularization procedures by relying on pharmacologic advances. The discovery of heparin by Jay McLean made this possible. The ability to dissolve occluding thrombus by activating the thrombolytic system with a variety of agents is currently being pursued to reestablish blood flow to an ischemic vascular bed, with the hope of achieving greater long-term clinical success and lower operative mortality.

Keywords

Thrombolytic Therapy Popliteal Artery Thrombolytic Agent Amputation Rate Anterior Tibial Artery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Taylor FB Jr, Botts J: Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen, Biochemistry 38: 1627, 1968.Google Scholar
  2. 2.
    Tillet WS, Garner RL: The fibrinolytic activity of hemolytic streptococci, J Exp Med 58: 485, 1933.CrossRefGoogle Scholar
  3. 3.
    Tillet WS, Sherry S: The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal deoxyribonuclease on fibrinous, purulent, and sanguineous pleural exudations, J Clin Invest 28: 173, 1949.CrossRefGoogle Scholar
  4. 4.
    Chesterman CN, Cederholm-Williams SA, Allington MJ: The degradation of streptokinase during the production of plasminogen activator, Thromb Res 5: 413, 1974.PubMedCrossRefGoogle Scholar
  5. 5.
    Rubin RN: Choosing a thrombolytic agent in acute myocardial infarction, Pharmacol Ther 17: 617, 1992.Google Scholar
  6. 6.
    James DC: Antistreptokinase levels in various hospital groups, Postgrad Med 49: 26, 1973.Google Scholar
  7. 7.
    MacFarlane RG, Pilling J: Fibrinolytic activity in normal urine, Nature 159: 779, 1947.PubMedCrossRefGoogle Scholar
  8. 8.
    Williams JRB: The fibrinolytic activity of urine, Br J Exp Pathol 32: 530–537, 1951.PubMedGoogle Scholar
  9. 9.
    Astrup T, Sterndorff I: An activator of plasminogen in normal urine, Proc Soc Exp Biol Med 81: 675, 1952.PubMedGoogle Scholar
  10. 10.
    Sobel GW, Mohler SR, Jones NW et al: Urokinase, an activator of profibnnolysin extracted from urine, Am J Physiol 171: 768–769, 1952.Google Scholar
  11. 11.
    Guenzler WA, Steffens GJ, Oetting F et al: The primary structure of high-molecular-mass urokinase from human urine: the complete amino acid sequence of the A chain, Hoppe-Seylers Z Physiol Chem 363: 1155, 1982.CrossRefGoogle Scholar
  12. 12.
    Verstraete M: Biochemical and clinical aspects of thrombolysis, Semin Hematol 15: 35, 1978.PubMedGoogle Scholar
  13. 13.
    Ratzkin B, Lee SG, Schrenk WJ et al: Expression in Escherichia coli of biologically active enzyme by a DNA sequence coding for the human plasminogen activator urokinase, Proc Natl Acad Sei USA 78: 3313–3317, 1981.CrossRefGoogle Scholar
  14. 14.
    Belkin M, Belkin B, Bucknam CA et al: Intraarterial fibrinolytic therapy: efficacy of streptokinase versus urokinase, Arch Surg 121: 769, 1986.PubMedCrossRefGoogle Scholar
  15. 15.
    Van Breda A, Katzen BT, Deutsch AS: Urokinase versus streptokinase in local thrombolysis, Radiology 165: 109, 1987.PubMedGoogle Scholar
  16. 16.
    Pennica D, Holmes WE, Kohr WJ et al: Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli, Nature 301: 214, 1983.Google Scholar
  17. 17.
    Rajput B, Degen SF, Reich et al: Chromosomal locations of human plasminogen activator and urokinase genes, Science 230: 672, 1985.PubMedCrossRefGoogle Scholar
  18. 18.
    Hoylaerts M, Rijken DC, Lijnen HR et al: Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay,J Lab Clin Med 101: 274, 1983.Google Scholar
  19. 19.
    TIMI Study Group: The thrombolysis in myocardial infarction (TIMI) trial: phase I findings, N Engl J Med 312: 932, 1985.Google Scholar
  20. 20.
    Gao S, Morser J, McLean K et al: Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase, Thromb Res 58: 421–433, 1990.PubMedCrossRefGoogle Scholar
  21. 21.
    Clifton EE: The use of plasmin in humans, Ann NY Acad Sei 68: 209–229, 1957.CrossRefGoogle Scholar
  22. 22.
    Dotter CT, Rosch J, Seaman AJ et al: Streptokinase treatment of thromboembolic disease, Radiology 102: 283–290, 1972.PubMedGoogle Scholar
  23. 23.
    Dotter CT, Rosch J, Seaman AJ: Selective clot lysis with low dose streptokinase, Radiology 111: 31–37, 1974.PubMedGoogle Scholar
  24. 24.
    Ouriel K, Shortell CK, DeWeese JA et al: A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral ischemia,/Vase Surg 19: 1021–1030, 1994.Google Scholar
  25. 25.
    Jivegard L, Holm J, Shersten T: The outcome in arterial thrombosis misdiagnosed as arterial embolism, Acta Chir Scand 152: 251–256, 1986.PubMedGoogle Scholar
  26. 26.
    Plecha FR, Poires WJ: Intraoperative angiography in the immediate assessment of arterial reconstruction, Arch Surg 105: 902–907, 1972.PubMedCrossRefGoogle Scholar
  27. 27.
    White GH, White RA, Kopchok GE et al: Angio-scopic thromboembolectomy; preliminary observation with a recent technique, J Vase Surg 7: 318–325, 1988.Google Scholar
  28. 28.
    Blaisdell FW, Steele M, Allen RE: Management of acute lower extremity arterial ischemia due to embolism and thrombosis, Surgery 84: 822–834, 1978.PubMedGoogle Scholar
  29. 29.
    Jivegard L, Holm J, Shersten T: Acute limb ischemia due to arterial embolism or thrombosis,/Cardiovasc Surg 29: 32–36, 1988.Google Scholar
  30. 30.
    McNamara TO, Bomberger RA, Merchant RF: Intra-arterial urokinase as the initial therapy for acutely ischemic lower limbs, Circulation 83 (suppl 1): 106–119, 1991.Google Scholar
  31. 31.
    Rutherford RB, Flanigan DP, Gupta SK et al: Suggested standards for reports dealing with lower extremity ischemia, J Vase Surg 4: 80–94, 1986.Google Scholar
  32. 32.
    Ricotta J: Intra-arterial thrombolysis: a surgical view, Circulation 83 (suppl 1): 120–121, 1991.Google Scholar
  33. 33.
    The STILE Investigators: Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity: the STILE Trial, Ann Surg 220: 251–268, 1994.CrossRefGoogle Scholar
  34. 34.
    Shortell CK, Ouriel K: Thrombolysis in acute peripheral arterial occlusion: predictors of immediate success, Ann Vase Surg 8: 59–65, 1994.CrossRefGoogle Scholar
  35. 35.
    Ouriel K, Veith FJ, Sasahara A A: Thrombolysis or peripheral arterial surgery: phase I results, J Vase Surg 23: 64–73, 1996.CrossRefGoogle Scholar
  36. 36.
    Ouriel K, Veith FJ, Sasahara AA et al: A comparison of recombinant urokinase with vascular surgery as the initial treatment for acute arterial occlusion of the legs, N Engl J Med 338: 1105–1111, 1998.PubMedCrossRefGoogle Scholar
  37. 37.
    Hoylaerts M, Jijken DC, Lijnen HR, Collen D: Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin,/Biol Chem 257: 2912–2919, 1982.Google Scholar
  38. 38.
    Strieker RB, Wong D, Tak Shiu D et al: Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation, Blood 68: 275–280, 1986.Google Scholar
  39. 39.
    DeMunk GAW, Caspers MPM, Chang GTG et al: Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments, Biochemistry 28: 7318–7325, 1989.CrossRefGoogle Scholar
  40. 40.
    Pannell R, Gurewich V: Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect, Blood 67: 1215–1223, 1986.PubMedGoogle Scholar
  41. 41.
    Mills JL, Harris EJ, Taylor LM et al: The importance of routine surveillance of distal bypass grafts with duplex scanning: a study of 379 reverse vein grafts, Vase Surg 12: 379–389, 1990.Google Scholar
  42. 42.
    Quinones-Balrich WJ, Prego A, Ucelay-Gomez R et al: Failure of PTFE infrainguinal revascularization: patterns, management, alternatives, and outcome, Ann Vase Surg 5: 163–169, 1991.CrossRefGoogle Scholar
  43. 43.
    Seabrook DF, Mewissen MW, Schmitt DD et al: Percutaneous intra-arterial thrombolysis in the treatment of thrombosis of lower extremity arterial reconstruction,/Vase Surg 13: 646–651, 1991.Google Scholar
  44. 44.
    Gardiner GA, Harrington DP, Koltun W et al: Salvage of occluded arterial bypass grafts by means of thrombolysis, J Vase Surg 13: 646–651, 1991.Google Scholar
  45. 45.
    Sullivan KL, Gardiner GA, Kandarpa K et al: Efficacy of thrombolysis in infrainguinal bypass grafts, Circulation 83 (suppl 1): 99–105, 1991.Google Scholar
  46. 46.
    Green RM, Ouriel K, Ricotta JJ et al: Revision of failed infrainguinal bypass grafts: principles of management, Surgery 100: 646–653, 1986.PubMedGoogle Scholar
  47. 47.
    Hye RJ, Turner C, Valji K et al: Is thrombolysis of occluded popliteal and tibial bypass grafts worthwhile? J Vase Surg 20: 588–597, 1994.CrossRefGoogle Scholar
  48. 48.
    Garcia R, Saroyan RM, Senkowsky J et al: Intraoperative intra-arterial urokinase infusion as an adjunct to Fogarty catheter embolectomy in acute arterial occlusion, Surg Gynecol Obstet 171: 971–978, 1990.Google Scholar
  49. 49.
    Quinones-Balrich WJ, Ziomek S, Henderson TC et al: Intraoperative fibrinolytic therapy: experimental evaluation, J Vase Surg 4: 229–236, 1986.CrossRefGoogle Scholar
  50. 50.
    Bevilacqua MP, Gimbrone: Inducible endothelial functions in inflammation and coagulation, Semin Thromb Hemost 13: 425–433, 1987.PubMedCrossRefGoogle Scholar
  51. 51.
    Jacobs GR, Reinisch JF, Puckett C: Microvascular fibrinolysis after ischemia: its relation to vascular patency and tissue survival, Blast Reconstr Surg 68: 737–741, 1981.CrossRefGoogle Scholar
  52. 52.
    Belkin M, Valeri R, Hobson RW: Intraarterial urokinase increases skeletal muscle viability after acute ischemia, J Vase Surg 9: 161–168, 1989.Google Scholar
  53. 53.
    Norem RF, Short DH, Kerstein MD: Role òf intraoperative fibrinolytic therapy in acute arterial occlusion, Surg Gynecol Obstet 167: 87–91, 1988.PubMedGoogle Scholar
  54. 54.
    Quinones-Balrich WJ, Baker JD, Busuttil RW et al: Intraoperative infusion of lytic drugs for thrombotic complications of revascularization, J Vase Surg 10: 408–417, 1989.CrossRefGoogle Scholar
  55. 55.
    Comerota A J, White JV: Intraoperative, intraarterial thrombolytic therapy as an adjunct to revascularization in patients with residual and distal arterial thrombus, Semin Vase Surg 5: 110–117, 1992.Google Scholar
  56. 56.
    Comerota A J, White JV, Grosch JD: Intraoperative, intra-arterial thrombolytic therapy for salvage of limbs in patients with distal arterial thrombosis, Surg Gynecol Obstet 169: 283–289, 1989.PubMedGoogle Scholar
  57. 57.
    Comerota AJ, Rao AK, Throm RC et al: A prospective, randomized, blinded, and placebo-controlled trial of intraoperative intra-arterial urokinase infusion during lower extremity revascularizations: regional and systemic effects, Ann Surg 218: 534, 1993.PubMedCrossRefGoogle Scholar
  58. 58.
    Thompson SG, Kienest J, Pyke SDM et al: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris, New Engl J Med 332: 635–641, 1995.PubMedCrossRefGoogle Scholar
  59. 59.
    Williams NS: Treatment of asymptomatic popliteal aneurysm: protection at a price, Br J Surg 79: 731–732, 1992.CrossRefGoogle Scholar
  60. 60.
    Gifford RW, Hines EA, James EA: An analysis and follow-up study of 100 popliteal aneurysms, Surgery 84: 775–783, 1953.Google Scholar
  61. 61.
    Dawson I, van Bockel H, Brand R et al: Popliteal artery aneurysms: long term follow-up of aneurysmal disease and results of surgical management, J Vase Surg 13: 398–407, 1991.CrossRefGoogle Scholar
  62. 62.
    Bouhoutsos J, Martin P: Popliteal aneurysms: a review of 116 cases, Br J Surg 61: 469–475, 1974.PubMedCrossRefGoogle Scholar
  63. 63.
    Shortell CK, DeWeese JA, Ouriel K et al: Popliteal artery aneurysms: a 25 year experience, J Vase Surg 14: 771–779, 1991.CrossRefGoogle Scholar
  64. 64.
    Cotton LT, Flute PT, Tsapogas MJC: Popliteal artery thrombosis treated with streptokinase, Lancet ii: 1081–1083, 1962.Google Scholar
  65. 65.
    Schwartz W, Berkowitz H, Taormina V et al: The preoperative use of intra-arterial thrombolysis for a thrombosed popliteal artery aneurysm, J Cardiovasc Surg 25: 465–468, 1984.Google Scholar
  66. 66.
    Ferguson LJ, Faris I, Robertson A et al: Intraarterial streptokinase therapy to relieve acute limb ischemia, J Vase Surg 4: 205–210, 1986.Google Scholar
  67. 67.
    Carpenter JP, Barker CF, Roberts B et al: Popliteal artery aneurysms: current management and outcome, J Vase Surg 19: 65–73, 1994.CrossRefGoogle Scholar
  68. 68.
    Varga ZA, Locke-Edmunds JC, Baird RN et al: A multicenter study of popliteal aneurysms, J Vase Surg 20: 171–177, 1994.CrossRefGoogle Scholar
  69. 69.
    Galland RB, Earnshaw JJ, Baird RN et al: Acute limb deterioration during intra-arterial thrombolysis, Br J Surg 80: 1118–1120, 1993.PubMedCrossRefGoogle Scholar
  70. 70.
    Thompson JF, Beard J, Scott DJA et al: Intraoperative thrombolysis in the management of thrombosed popliteal aneurysm, Br J Surg 80: 858–859, 1993.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Carlos E. Donayre
  • Kenneth Ouriel

There are no affiliations available

Personalised recommendations